Ep12. Tech Stocks vs the Rest; AI VC Bubble, Calcium CT Scan | BG2 with Bill Gurley & Brad Gerstner

Episode Summary

Executive Summary: The episode spans three major themes: market positioning ahead of the U.S. election, the tension between AI hype and real economic payoff, and a consumer-health PSA on calcium CT scans. The hosts argue that tech’s strength reflects expected Trump tax-cut permanence, likely Fed cuts, and concentrated earnings growth in the Mag 7, while warning that AI capex may be running ahead of revenues—especially for venture-backed startups. They close by urging broader adoption of low-cost preventative heart screening.

Main Topics: Election-driven market positioning (Priority: 5/5): The hosts discuss how investors are positioning ahead of the Republican and Democratic conventions and the election, with markets pricing in a Trump victory and a likely Fed rate cut. Tech leadership and market dispersion (Priority: 5/5): They explain that Mag 7 earnings growth is driving index performance while the rest of the market remains weak, creating major dispersion between large-cap tech and everything else. Passive flows vs active selling (Priority: 4/5): The conversation contrasts visible hedge-fund selling in tech with the reality that passive flows continue to support large-cap names, meaning active positioning is only part of the story. AI hype, capex, and return-on-investment risk (Priority: 5/5): They debate whether AI spending is outpacing monetization, citing skepticism from Sequoia, Goldman Sachs, and McKinsey, while defending the long-term promise of the technology. Venture capital vulnerability in AI (Priority: 4/5): The hosts argue that public mega-cap platforms can absorb missteps, but venture-backed AI startups face existential pressure if revenues do not catch up with lofty valuations. Calcium CT scans as preventative medicine (Priority: 5/5): The final segment advocates for calcium CT scans as a low-cost, underused heart-disease screening tool that should be standard of care for adults over 35-40. Healthcare incentives and institutional inertia (Priority: 4/5): They suggest the medical system favors profitable treatment over prevention, with insurance, procedural incentives, and inertia slowing adoption of preventative screening.

Key Arguments: Markets are being driven by expectations of a Trump win, which could preserve corporate tax cuts that have materially boosted earnings since 2017. The probability of a Fed rate cut has risen because unemployment is ticking up, discretionary spending is softening, and core PCE is rolling over. Tech strength is narrow: Mag 7 earnings are up sharply while the S&P 500 ex-tech is flat to down, creating a highly concentrated market. Despite broad optimism, hedge funds have been reducing tech exposure; May and June were among the largest months of tech selling since 2010. Passive flows matter: only about one-tenth of large-cap tech dollars are active, so ETF/401(k) inflows can overwhelm active selling. AI investment may be ahead of monetization, especially in venture-backed startups that need durable revenue to justify high valuations. Public mega-caps are less fragile because they can shift compute and absorb capex mistakes; venture-funded startups have much higher mortality risk. LLMs may face diminishing marginal returns, and it remains unclear whether the future value will come mainly from cost reduction or new revenue. Calcium CT scans can catch plaque early, but remain underused because of institutional inertia and misaligned incentives. The hosts argue prevention is more rational than waiting for heart disease to manifest, and that the scan should be treated like a mammogram for the heart.

Data Points: Days until election: 90 market days - Used to frame market positioning ahead of the U.S. presidential election. NASDAQ year-to-date performance: Up 20% - Referenced as evidence of continued large-cap tech strength. Market-implied Trump victory probability: 60% - Used to explain expectations around tax policy and market sentiment. Market-implied Fed rate-cut probability before election: 73% - Based on pricing around the two remaining Fed meetings before the election. Fed meetings before election: 2 - July 31 and September 18 meetings were cited. Tech selling months: May and June were two of the top three largest months of tech selling since 2010 - Morgan Stanley data cited to show active managers were de-risking tech. Active dollars in large-cap tech: 11% to 12% - Share of dollars in large-cap tech managed by active investors today. Active dollars in large-cap tech in 2010: Above 20% - Historical comparison showing active ownership has fallen. Mag 7 earnings growth: Up 38% over the last 12 months - Goldman Sachs data used to explain index concentration. S&P 500 earnings growth: Roughly flat - Shows index-level earnings growth is not broad-based. S&P 500 ex-tech earnings growth: Down 5% - Highlights weakness in the other 495 names. Apple forward P/E: 32x - Above its 2021 peak of 28x. Meta forward P/E: 24x - Above its 2021 peak of 22x. Google forward P/E: 23x - Near its prior peak of 24x. Amazon forward P/E: 33x - Below prior peak/trough range discussed, after cost cuts and earnings growth. Microsoft forward P/E: 35x - Near its prior peak of 37x. NVIDIA forward P/E: 40x - Recovered from a trough around 20x; below its peak of 66x. Calcium CT scan cost: $150 - Presented as a low-cost preventative screening tool. Mobile calcium CT scan price in Seattle: $55 - Example of a very low-cost access point mentioned. Women’s heart-attack mortality vs breast cancer: 5x more women die of heart attack each year than breast cancer - Used to argue for broader adoption of heart screening. AI buildout referenced: $2 trillion - Earlier discussion about projected NVIDIA/AI infrastructure spending over four to five years. AI revenue question: $600 billion question - Referenced Sequoia’s framing of the revenue gap versus investment. AWS investment period: Over $100 billion and 8+ years before profitability - Used as an analogy for long-duration infrastructure investment. Reality Labs investment: $20 billion per year for a decade - Used to argue big tech can sustain large strategic bets. OpenAI subscription spend: $3 billion - Referenced as real consumer willingness to pay for AI services.

Pivotal Quotes: "We may have created a healthcare industrial complex that really can't stop maximizing profitability and different ways of making money and not focus necessarily on the lowest cost, best, most preventative process." — Speaker: Opening critique of incentives in healthcare before shifting into the calcium CT scan discussion. "Is the AI hype ahead of the meat?" — Speaker: Frame for the AI segment questioning whether spending and valuations are outrunning revenues and utility. "I think the whole ecosystem needs to be prepared for that." — Speaker: Satya Nadella reference about possible drawdowns between now and long-term AI benefits.

Implications: Investors should expect a concentrated market, election-sensitive positioning, and heightened AI valuation risk. In healthcare, the episode argues that low-cost preventive screening is being delayed by incentives and inertia, not science.